Egfr Mutations in Lung Cancer Molecular Difficulty

[Chapman1]

Not always. While Egfr mutations are robust predictors of response to Tkis, other factors like the type of mutation, tumor heterogeneity, and acquired resistance mechanisms can influence treatment method outcomes. It's a complex scenery that requires personalized approaches.